At the news
? NEUTRALIMPACT 3/10 8-K filed Nov 13, 2026 at 16:01 ET
Moderna entered into a Transitional Services and Retirement Agreement with Chief Legal Officer Shannon Thyme Klinger, who will retire effective March 31, 2027. She will remain employed through that date to assist with the CLO search and litigation transitions, receiving $1.63M in severance plus contingent litigation success payments of up to $8.0M. The departure is a planned retirement with a named transition period and no replacement named yet.
- Shannon Thyme Klinger, Chief Legal Officer, will retire effective March 31, 2027
- She will continue employment through a transition period to assist with CLO search and litigation matters
- Severance pay of $1,628,300 (12 months base salary plus target bonus) paid biweekly over 12 months
- Contingent litigation success payments: $2.5M if Moderna prevails in Arbutus case; up to $5.5M from Pfizer litigation recovery
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access